These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Search MEDLINE/PubMed
Title: Preliminary results of short-term combination immunosuppressions of mizoribine, azathioprine, and prednisolone with pretreatment to canine kidney transplantation. Author: Minami T, Watanabe T, Muto M, Wakao Y, Suzuki T, Takahashi M. Journal: J Vet Med Sci; 1993 Jun; 55(3):409-14. PubMed ID: 8357913. Abstract: Serial combinations of immunosuppressive drugs (mizoribine: Mi, azathioprine: Az, and prednisolone: Pr) were administered for renal heterotopic allotransplantation in 50 mixed-breed dogs and 4 beagle dogs. The dogs were randomly divided in 5 groups depending upon immunosuppressive protocols. All immunosuppressive protocols were started at 5 days prior to transplantation and discontinued on the eighth day after transplantation. The mean survival time for the allograft recipients in the group receiving Az and Pr [Az (2.5) & Pr group; Az dosage, 2.5 mg/kg once a day with Pr] was 16.2 +/- 2.4 days and in the group receiving Az, Mi, and Pr (Mi & Az & Pr group; Mi dosage, 5.0 mg/kg once a day with Az and Pr), it was 14.0 +/- 2.6 days. These results were significantly longer than the control group (mean survival time, 8.7 +/- 2.4 days; P < 0.01). There was no statistical difference in survival time between these two groups. Groups with combinations of Az and Pr had significant elevations of hepatic enzymes (ALT and ALP) during the 7 days of immunosuppressive treatment after kidney transplantation. The Mi & Az & Pr group had lower elevations of hepatic enzymes than groups with combinations of Az and Pr. The combination immunosuppression of Mi, Az, and Pr with pre-treatment for canine, kidney transplantation revealed relatively fewer side-effects for the liver and longer survival-time.[Abstract] [Full Text] [Related] [New Search]